Show simple item record

dc.contributor.advisorWessels, J C
dc.contributor.authorDu Plessis, Leandri
dc.date.accessioned2018-06-13T09:34:10Z
dc.date.available2018-06-13T09:34:10Z
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/10394/27510
dc.descriptionMSc (Pharmaceutical Chemistry), North-West University, Potchefstroom Campus, 2018en_US
dc.description.abstractThe possible treatment and prevention of Alzheimer’s disease (AD) is one of many clinical applications of methylene blue (MB) that has recently attracted much interest. Due to its ability to interact with various targets, MB exhibits multiple mechanisms by which the progression of neurodegenerative diseases may be decreased. Recently, it has been reported that azure B (AB), the major metabolite of MB, possesses superior effects at various pharmacological targets compared to MB. This finding raises the question that much of the documented pharmacological effects of MB observed in previous studies may in fact be due to the actions of AB. The structural similarities between MB and its metabolites have made the analysis of these compounds very challenging. The published analytical methods for MB and its metabolites have significant disadvantages such as low sensitivity, uneconomically high costs, the need of professionally trained personnel and very expensive, high technology apparatus. These disadvantages delays and limits the research into MB as a drug for the treatment of AD and other neurodegenerative disorders, and also hampers investigations into the pharmacology of MB. In this study, simple and cost effective analytical methods were developed to analyse and separate MB and its metabolites. An accurate, sensitive and reliable high performance liquid chromatography (HPLC) method with which MB and its metabolites were successfully separated, was developed and fully validated. A Synergi Polar-RP column (150 x 4.6 mm, 4 μ, 80 Å) and a mobile phase composed of two parts: ammoniumacetate that is dissolved in a mixture of water and methanol (part A) and a mixture of acetonitrile and methanol (part B). The analysis were done on a Hitachi Chromaster chromatographic system. Also, successful normal phase and reverse phase thin layer chromatography (TLC) methods were developed as a crude method for accessing the purity of MBen_US
dc.description.sponsorshipNational Research Foundation (NRF)en_US
dc.language.isoenen_US
dc.publisherNorth-West University (South Africa), Potchefstroom Campusen_US
dc.subjectMethylene blueen_US
dc.subjectAzure Ben_US
dc.subjectAlzheimer's diseaseen_US
dc.subjectMethod developmenten_US
dc.subjectHigh performance liquid chromatographyen_US
dc.subjectValidationen_US
dc.titleThe development of simple HPLC methods to separate methylene blue and its metabolitesen_US
dc.typeThesisen_US
dc.description.thesistypeMastersen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record